Mental Health. Clarity. Balance.
Depression

Diagnosing and Treating Major Depressive Disorder With Mixed Features

Diagnostic Challenges in Clinical Practice The DSM-5 criterion for mixed episodes requires three concurrent manic symptoms.

Diagnosing and Treating Major Depressive Disorder With Mixed Features

Diagnostic Challenges in Clinical Practice

The DSM-5 criterion for mixed episodes requires three concurrent manic symptoms. Distinguishing this from prior bipolar history remains difficult. In the US, many patients were treated as unipolar for years. This diagnostic error is common and often persists for years before correction.

National VA Mental Health Program Findings

The US Department of Veterans Affairs evaluated over 2,000 patients. Methods included medical record review and videoconferencing. Many were referred for diagnostic consultation due to suspected bipolar signs. Most had previously received antidepressants despite bipolar history.

Using Narrative Descriptions to Improve Diagnosis

Descriptive narratives of hypomanic episodes aid short evaluations. These cover all DSM-5-TR symptoms. They show the typical trajectory from onset to resolution. Patients often recognize their own experience for the first time. This helps confirm or deny the description based on personal history.

Pre-Bipolar Phase and Predictive Factors

Even without clear manic history, patients may be in a pre-bipolarphase. This indicates high probability of future manic episodes. A panel of experts identified predictive factors. These include family history of bipolar disorder. Other factors: young age at onset, panic-level anxiety, family history of suicide, irritability after antidepressants, and psychotic symptoms.

Pharmacological Treatment Approaches

When predictive factors are present, use bipolar depression medications. Avoid standard antidepressants. Two FDA-approved therapies showed efficacy in placebo-controlled trials. The VA/DoD practice guide and Harvard South Shore algorithm recommend specific drugs. These include quetiapine, lurasidone, cariprazine, lumateperone, and lithium plus lamotrigine. Drug choice must consider medical status, side effects, patient preference, and local availability. Cariprazine and lumateperone are expensive and may have access restrictions.

Managing Treatment Resistance

If initial medication fails or causes intolerance, switch to another recommended regimen. If response remains unsatisfactory, try a standard antidepressant like bupropion or an SSRI. However, avoid these if there is a history of rapid cycling or worsening after prior antidepressant use. In such cases, explore more combinations of the five initial regimens. Then consider options for treatment-resistant bipolar depression, though clinical evidence is limited.

Research Needs and Expert Leadership

There is an urgent need for more research on treating mixed features. Dr. Osser, associate professor of psychiatry at Harvard Medical School and VA Boston, coordinates the national telemedicine program for bipolar disorders at the Department of Veterans Affairs.

More stories:

Share:

Leave a comment